Copyright Reports & Markets. All rights reserved.

Global Glycogen Synthase Kinase 3 Beta Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Glycogen Synthase Kinase 3 Beta Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Glycogen Synthase Kinase 3 Beta Market Size Growth Rate by Product
      • 1.4.2 AP-001
      • 1.4.3 AP-1
      • 1.4.4 DM-204
      • 1.4.5 Neu-120
      • 1.4.6 Others
    • 1.5 Market by End User
      • 1.5.1 Global Glycogen Synthase Kinase 3 Beta Market Size Growth Rate by End User
      • 1.5.2 Musculoskeletal Disorder
      • 1.5.3 Lung Cancer
      • 1.5.4 Dyskinesia
      • 1.5.5 Menkes Disease
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Glycogen Synthase Kinase 3 Beta Market Size
      • 2.1.1 Global Glycogen Synthase Kinase 3 Beta Revenue 2014-2025
      • 2.1.2 Global Glycogen Synthase Kinase 3 Beta Sales 2014-2025
    • 2.2 Glycogen Synthase Kinase 3 Beta Growth Rate by Regions
      • 2.2.1 Global Glycogen Synthase Kinase 3 Beta Sales by Regions
      • 2.2.2 Global Glycogen Synthase Kinase 3 Beta Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Glycogen Synthase Kinase 3 Beta Sales by Manufacturers
      • 3.1.1 Glycogen Synthase Kinase 3 Beta Sales by Manufacturers
      • 3.1.2 Glycogen Synthase Kinase 3 Beta Sales Market Share by Manufacturers
      • 3.1.3 Global Glycogen Synthase Kinase 3 Beta Market Concentration Ratio (CR5 and HHI)
    • 3.2 Glycogen Synthase Kinase 3 Beta Revenue by Manufacturers
      • 3.2.1 Glycogen Synthase Kinase 3 Beta Revenue by Manufacturers (2014-2019)
      • 3.2.2 Glycogen Synthase Kinase 3 Beta Revenue Share by Manufacturers (2014-2019)
    • 3.3 Glycogen Synthase Kinase 3 Beta Price by Manufacturers
    • 3.4 Glycogen Synthase Kinase 3 Beta Manufacturing Base Distribution, Product Types
      • 3.4.1 Glycogen Synthase Kinase 3 Beta Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Glycogen Synthase Kinase 3 Beta Product Type
      • 3.4.3 Date of International Manufacturers Enter into Glycogen Synthase Kinase 3 Beta Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Glycogen Synthase Kinase 3 Beta Sales by Product
    • 4.2 Global Glycogen Synthase Kinase 3 Beta Revenue by Product
    • 4.3 Glycogen Synthase Kinase 3 Beta Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Glycogen Synthase Kinase 3 Beta Breakdown Data by End User

    6 North America

    • 6.1 North America Glycogen Synthase Kinase 3 Beta by Countries
      • 6.1.1 North America Glycogen Synthase Kinase 3 Beta Sales by Countries
      • 6.1.2 North America Glycogen Synthase Kinase 3 Beta Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Glycogen Synthase Kinase 3 Beta by Product
    • 6.3 North America Glycogen Synthase Kinase 3 Beta by End User

    7 Europe

    • 7.1 Europe Glycogen Synthase Kinase 3 Beta by Countries
      • 7.1.1 Europe Glycogen Synthase Kinase 3 Beta Sales by Countries
      • 7.1.2 Europe Glycogen Synthase Kinase 3 Beta Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Glycogen Synthase Kinase 3 Beta by Product
    • 7.3 Europe Glycogen Synthase Kinase 3 Beta by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Glycogen Synthase Kinase 3 Beta by Countries
      • 8.1.1 Asia Pacific Glycogen Synthase Kinase 3 Beta Sales by Countries
      • 8.1.2 Asia Pacific Glycogen Synthase Kinase 3 Beta Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Glycogen Synthase Kinase 3 Beta by Product
    • 8.3 Asia Pacific Glycogen Synthase Kinase 3 Beta by End User

    9 Central & South America

    • 9.1 Central & South America Glycogen Synthase Kinase 3 Beta by Countries
      • 9.1.1 Central & South America Glycogen Synthase Kinase 3 Beta Sales by Countries
      • 9.1.2 Central & South America Glycogen Synthase Kinase 3 Beta Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Glycogen Synthase Kinase 3 Beta by Product
    • 9.3 Central & South America Glycogen Synthase Kinase 3 Beta by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Glycogen Synthase Kinase 3 Beta by Countries
      • 10.1.1 Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales by Countries
      • 10.1.2 Middle East and Africa Glycogen Synthase Kinase 3 Beta Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Glycogen Synthase Kinase 3 Beta by Product
    • 10.3 Middle East and Africa Glycogen Synthase Kinase 3 Beta by End User

    11 Company Profiles

    • 11.1 Mitsubishi Tanabe Pharma Corp
      • 11.1.1 Mitsubishi Tanabe Pharma Corp Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Products Offered
      • 11.1.5 Mitsubishi Tanabe Pharma Corp Recent Development
    • 11.2 Neurim Pharmaceuticals Ltd
      • 11.2.1 Neurim Pharmaceuticals Ltd Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Products Offered
      • 11.2.5 Neurim Pharmaceuticals Ltd Recent Development
    • 11.3 Actuate Therapeutics Inc
      • 11.3.1 Actuate Therapeutics Inc Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Products Offered
      • 11.3.5 Actuate Therapeutics Inc Recent Development
    • 11.4 DiaMedica Therapeutics Inc
      • 11.4.1 DiaMedica Therapeutics Inc Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Products Offered
      • 11.4.5 DiaMedica Therapeutics Inc Recent Development
    • 11.5 Angelini Group
      • 11.5.1 Angelini Group Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Angelini Group Glycogen Synthase Kinase 3 Beta Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Angelini Group Glycogen Synthase Kinase 3 Beta Products Offered
      • 11.5.5 Angelini Group Recent Development
    • 11.6 Jeil Pharmaceutical Co Ltd
      • 11.6.1 Jeil Pharmaceutical Co Ltd Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Products Offered
      • 11.6.5 Jeil Pharmaceutical Co Ltd Recent Development
    • 11.7 AMO Pharma Ltd
      • 11.7.1 AMO Pharma Ltd Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Products Offered
      • 11.7.5 AMO Pharma Ltd Recent Development

    12 Future Forecast

    • 12.1 Glycogen Synthase Kinase 3 Beta Market Forecast by Regions
      • 12.1.1 Global Glycogen Synthase Kinase 3 Beta Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Glycogen Synthase Kinase 3 Beta Revenue Forecast by Regions 2019-2025
    • 12.2 Glycogen Synthase Kinase 3 Beta Market Forecast by Product
      • 12.2.1 Global Glycogen Synthase Kinase 3 Beta Sales Forecast by Product 2019-2025
      • 12.2.2 Global Glycogen Synthase Kinase 3 Beta Revenue Forecast by Product 2019-2025
    • 12.3 Glycogen Synthase Kinase 3 Beta Market Forecast by End User
    • 12.4 North America Glycogen Synthase Kinase 3 Beta Forecast
    • 12.5 Europe Glycogen Synthase Kinase 3 Beta Forecast
    • 12.6 Asia Pacific Glycogen Synthase Kinase 3 Beta Forecast
    • 12.7 Central & South America Glycogen Synthase Kinase 3 Beta Forecast
    • 12.8 Middle East and Africa Glycogen Synthase Kinase 3 Beta Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Glycogen Synthase Kinase 3 Beta Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Glycogen Synthase Kinase 3 Beta market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Glycogen Synthase Kinase 3 Beta market based on company, product type, end user and key regions.

      This report studies the global market size of Glycogen Synthase Kinase 3 Beta in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Glycogen Synthase Kinase 3 Beta in these regions.
      This research report categorizes the global Glycogen Synthase Kinase 3 Beta market by top players/brands, region, type and end user. This report also studies the global Glycogen Synthase Kinase 3 Beta market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Mitsubishi Tanabe Pharma Corp
      Neurim Pharmaceuticals Ltd
      Actuate Therapeutics Inc
      DiaMedica Therapeutics Inc
      Angelini Group
      Jeil Pharmaceutical Co Ltd
      AMO Pharma Ltd

      Market size by Product
      AP-001
      AP-1
      DM-204
      Neu-120
      Others
      Market size by End User
      Musculoskeletal Disorder
      Lung Cancer
      Dyskinesia
      Menkes Disease
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Glycogen Synthase Kinase 3 Beta market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Glycogen Synthase Kinase 3 Beta market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Glycogen Synthase Kinase 3 Beta companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Glycogen Synthase Kinase 3 Beta submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Glycogen Synthase Kinase 3 Beta are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Glycogen Synthase Kinase 3 Beta market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now